SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on December 28, 2022, covering events occurring on December 27, 2022. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The filing addresses corporate governance amendments rather than operational or financial performance updates.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The primary material change reported is the adoption of Amendment No. 2 to the Company's Amended and Restated Bylaws. Effective December 27, 2022, the Board of Directors lowered the quorum threshold required for stockholder meetings. The new requirement is one-third of the voting power of stock issued, outstanding, and entitled to vote, present in person or by proxy, replacing the previous threshold.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks, contingencies, or unusual items were disclosed in this report beyond the standard incorporation of the bylaw amendment text.
Key Facts for Investor Verification
- Verify the exact previous quorum threshold to understand the magnitude of the governance change.
- Confirm the effective date of the bylaw amendment is December 27, 2022.
- Note that this filing does not impact the company's financial position or operational results.
- Review the full text of Amendment No. 2 (Exhibit 3.1) for any additional clauses not summarized in Item 5.03.